Treatment of skin disease

Treatment of skin disease

by Mark G. Lebwohl, Warren R. Heymann, John Berth-jones, Ian Coulson

Browse books you can read free on Readfeed

No club is reading this yet — be the first to start one

Start a club free
About
"Treatment of Skin Disease: Comprehensive Therapeutic Strategies has been thoroughly revised to give you the latest treatment options for dermatologic conditions. Mark G. Lebwohl, Warren R. Heymann, John Berth-Jones, and Ian Coulson present an intuitive and easy-to-use, definitive treatment reference that covers the full range of choices for each condition so that you are prepared even when your patients do not respond to primary or secondary therapies. With new chapters on today's hot topics-methocillin-resistant staphylococcus aureus, atypical nevi, autoimmune progesterone dermatitis, and more-and new contributions from international experts, you'll have a global and current perspective on therapeutic options. Offer your patients the full range of choices and be prepared when your patients do not respond to primary or secondary therapies."--Publisher's website.

Discuss Treatment of skin disease with other readers

Join or start a book club for Treatment of skin disease on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Treatment of skin disease?

Sign up free on Readfeed, then browse public clubs or start your own club with Treatment of skin disease as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Treatment of skin disease with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Treatment of skin disease with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.